Dr. Lakin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
241 N Superior St
Suite 102
Toledo, OH 43604Phone+1 419-214-3220Fax+1 866-271-1135
Education & Training
University of Toledo College of LawJ.D., 2014 - 2018
University Hospitals Cleveland Medical CenterPost-Doctoral Fellowship, 2011 - 2013
Cleveland Clinic FoundationFellowship, Research, 2009 - 2011
Akron General Medical Center/NEOMEDResidency, Surgery, 2008 - 2009
Nassau University Medical CenterResidency, Surgery, 2007 - 2008
Ascension Illinois/Saint Joseph (Chicago)Residency, Surgery, 2005 - 2007
Southern Illinois University School of MedicineClass of 2005
Certifications & Licensure
MI State Medical License 2013 - 2026
OH State Medical License 2008 - 2026
FL State Medical License 2015 - 2025
NC State Medical License 2020 - 2023
CT State Medical License 2021 - 2022
IL State Medical License 2005 - 2017
Clinical Trials
- Optical Imaging Measurement of Intravascular Solution Efficacy Trial Start of enrollment: 2012 Sep 01
Publications & Presentations
PubMed
- 82 citationsThe contemporary management of splenic artery aneurysmsRyan O. Lakin, James Bena, Timur P. Sarac, Samir K. Shah, Leonard P. Krajewski
Journal of Vascular Surgery. 2010-06-01 - 12 citationsPulse volume recording does not enhance segmental pressure readings for peripheral arterial disease stratification.Benjamin A. Eslahpazir, Matthew T. Allemang, Ryan O. Lakin, Teresa L. Carman, Michael R. Trivonovich
Annals of Vascular Surgery. 2014-01-01 - 8 citationsThe LargPAD Trial: Phase IIA evaluation of l-arginine infusion in patients with peripheral arterial diseaseVikram S. Kashyap, Ryan O. Lakin, Patricia R. Campos, Matthew T. Allemang, Ann H. Kim
Journal of Vascular Surgery. 2017-07-01
Press Mentions
RYAH Group and OMNI Announce Collaboration for Clinical Study in Cannabis for Treatment of COVID-19January 3rd, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
